Erratum: JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
Saved in:
Format: | Article |
---|---|
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Online Access: | https://journals.lww.com/10.4103/jfmpc.jfmpc_1986_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Lipids Alterations in Patients Under Systemic JAK Inhibitors Treatments in Dermatology: Clinical Aspects and Management
by: Giovanni Paolino, et al.
Published: (2025-01-01) -
JAK inhibitors: a new choice for diabetes mellitus?
by: Mengjun Zhou, et al.
Published: (2025-01-01) -
Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry
by: Yoshiya Tanaka, et al.
Published: (2025-01-01) -
Monocyte STAT1 phosphorylation and treatment response of JAK inhibitors in chronic nonbacterial osteomyelitis
by: Motoshi Sonoda, et al.
Published: (2025-01-01) -
MEK1/2 Inhibitor (GDC0623) Promotes Osteogenic Differentiation of Primary Osteoblasts Inhibited by IL-1β through the MEK-Erk1/2 and Jak/Stat3 Pathways
by: Zeng-Qiao Zhang, et al.
Published: (2021-01-01)